European Medicines Agency at TIDES Europe 2026
Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website
European Medicines Agency takes part in 2 sessions at TIDES Europe 2026 in Amsterdam, its home city. Its sessions set out the European regulator's perspective on synthetic peptides, oligonucleotides, and mRNA vaccines and therapeutics. They include updates to the guidelines that apply to synthetic peptides and oligonucleotides.
| Organization | TIDES Europe 2026 Attendance |
|---|---|
European Medicines Agency Amsterdam, Netherlands | |
European Union agency that evaluates and supervises medicines, including oligonucleotide and peptide products. | Talk Wed Nov 4 15:00–15:30 EMA Perspectives on mRNA Vaccines and Therapeutics Where European regulators stand on quality rules for mRNA vaccines and medicines, and which problems keep coming up in applications. Talk Wed Nov 4 09:05–09:35 Regulatory Landscape for Synthetic Peptides and Oligonucleotides: EMA Insights and Guideline Updates An update on two draft European guidelines for synthetic peptides and oligonucleotides, the feedback they drew and the problems seen in filings. |
Instantly find 20 buyers from European Medicines Agency
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or TIDES Europe. Submit a correction